Research summary, original research, 2026

Assessment of Radiation Dose in Neurointerventional Procedures Using a Modern Digital Fluoroscopy System

Olgar T, Ariman S, Yalcin A, Arat A, Sancak T. Health physics. 2026

Read the original paper

In plain language

In neurointerventional angiography on one modern system, per-procedure doses were measured for interventional radiologists, nurses and technologists. Eye lens doses were similar for all three roles, with nurses slightly highest, while the interventional radiologist had the highest extremity and whole-body doses.

At a glance

Type of study
Original research, Dosimetry measurement study
Who was studied
Interventional radiologists, Nurses, Radiologic technologists, Patients
Size
n = 86 patients (staff dose measured in 38 examinations)
Summary based on
the abstract

What it found

  • Per-procedure eye lens doses were similar across roles, with the nurse slightly higher than the interventional radiologist.

    Key figures: 18.7, 19.7, and 13.4 µSv (IR, nurse, technologist)

  • Extremity dose per procedure was highest for the interventional radiologist.

    Key figures: 54.7 µSv interventional radiology (IR); 15.3 µSv nurse; 14.2 µSv technologist

  • Whole-body effective dose per examination was highest for the interventional radiologist, followed by the technologist and nurse.

    Key figures: 12.6, 7.1, and 10.0 µSv (IR, nurse, technologist)

  • Patient dose was higher for cerebral than carotid procedures, and higher for therapeutic than diagnostic procedures.

    Key figures: Cerebral mean dose-area product (DAP) 73/143 Gy cm2, cumulative air kerma (CAK) 657/1,888 mGy; carotid DAP 40/79 Gy cm2, CAK 487/679 mGy

  • Patient effective doses estimated from DAP.

    Key figures: 4.04/8.16 mSv cerebral; 2.11/3.93 mSv carotid (diagnostic/therapeutic)

Limits to keep in mind

Single fluoroscopy system with a small staff-dose sample (38 examinations), and eye and extremity doses were inferred from collar and body dosimeters rather than dedicated eye or ring dosimeters as far as the abstract states. Country and shielding use are not reported in the abstract.

How this summary was made

ORSIF prepared this summary with AI assistance from the abstract of the paper. A program then checked that the passage supporting each finding appears word for word in that source. A person has not yet reviewed each summary, so read the original before relying on a number. ORSIF summarizes research and does not endorse any product or company. Report a problem with this summary.

Prepared November 3, 2026.